mRNA-Based Therapeutics Development Through Efficient mRNA Purification

The rapid advancements in mRNA-based therapeutics, spurred by the COVID-19 pandemic, have opened up a vast clinical pipeline with seemingly endless potential. As this development accelerates, the life sciences industry urgently needs efficient and scalable manufacturing techniques to meet commercial demand.

This webinar explores a crucial step in that scale-up: the purification of mRNA. Discover how a novel affinity resin, the POROS™ Oligo dT(25), simplifies and maximizes efficiency by utilizing a straightforward AT base-pairing mechanism to bind to the poly-A tail found on all mRNA molecules. Learn about the benefits of affinity capture and see how this platform can streamline your mRNA purification process, from initial benchwork straight through to full-scale manufacturing.